By immunostaining of Ki-67, an index of cell proliferation, it was observed that celecoxib therapy significantly decreased the Ki-67-positive proliferating cells in hepatoma tissues (Fig. 4D). The gene discussed is MKI67; the disease is hepatocellular carcinoma.